Biologics during early development workflows
6 May 2024Biophysical characterization measurements, such as nanoDSF, dynamic light scattering (DLS), backreflection, and static light scattering (SLS), are used to provide information on stability and other developability attributes without using a lot of material. NanoTemper Technologies outlines a workflow for the development and screening of biologic drugs. The process aims to identify promising candidates early on in the pipeline to avoid wasting investment costs. The workflow covers various stages, including candidate library development, formulation optimization, developability screening, pre-clinical characterization, and investigational new drug approval.
Links
Tags
Sample ManagementSample management systems include sample storage devices such as freezers and plate storers, sample environment enclosures and sample organization, retrieval and sorter systems. Useful system features include high-throughput, automation, robotic arms, automated liquid handling and associated database systems. Accessories in sample management include barcode scanners, heat sealers and tubes.Drug DeliveryDrug Delivery refers to dosage form, route of administration, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via the biopharmaceutical or small molecule drug's formulation, but it may also involve medical devices or drug-device combination products. Considerations include instrumentation, software and services. BiologicsBiologics are medical products derived from living organisms, including vaccines, gene therapies, and monoclonal antibodies. These treatments are key to modern healthcare, especially in oncology and autoimmune diseases. Explore biologics research tools in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.Drug DevelopmentDrug development refers to the process of bringing a new drug to market.